FMP
NASDAQ
0.057 USD
0 (0%)
Dr. Douglas Edward Williams Ph.D.
Healthcare
Biotechnology
https://www.codiakbio.com
NASDAQ
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington...
0001659352
US1920101060
192010106
35 Cambridge Park Drive
617 949 4100
US
102
Oct 14, 2020
0001659352
NASDAQ
Biotechnology
Healthcare
192010106
US1920101060
US
0.06
3.93
1.6M
2.83M
-
0.017-4.25
0
-
-
-
-
-0.12
-
https://www.codiakbio.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.